2020
DOI: 10.6065/apem.2020.25.1.15
|View full text |Cite
|
Sign up to set email alerts
|

Bone health in pediatric patients with neurological disorders

Abstract: Patients with neurological disorders are at high risk of developing osteoporosis, as they possess multiple risk factors leading to low bone mineral density. Such factors include inactivity, decreased exposure to sunlight, poor nutrition, and the use of medication or treatment that can cause lower bone mineral density such as antiepileptic drugs, ketogenic diet, and glucocorticoids. In this article, mechanisms involved in altered bone health in children with neurological disorders and management for patients wi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
20
0
5

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(25 citation statements)
references
References 99 publications
(150 reference statements)
0
20
0
5
Order By: Relevance
“…The bone mineral density in the proximal femur was reported to be considerably diminished even when gait was minimally affected; then it progressively decreased to nearly 4 standard deviations below the age-matched normal [ 7 ]. Calcium and vitamin D or alendronate administration are investigational treatments to improve bone mineral density, and eventually to reduce the fracture risk [ 9 11 ].…”
Section: Discussionmentioning
confidence: 99%
“…The bone mineral density in the proximal femur was reported to be considerably diminished even when gait was minimally affected; then it progressively decreased to nearly 4 standard deviations below the age-matched normal [ 7 ]. Calcium and vitamin D or alendronate administration are investigational treatments to improve bone mineral density, and eventually to reduce the fracture risk [ 9 11 ].…”
Section: Discussionmentioning
confidence: 99%
“…A high incidence of renal calculi with hypercalciuria have been reported in patients on KD, suggesting a major effect of the KD on calcium metabolism [ 129 , 130 ]. KD-related calcium and bone mass deficiency were originally reported in five children maintained chronically on combined KD-anticonvulsant drug therapy [ 131 ].…”
Section: How Could Kds and Kbs Affect Bone Metabolism?mentioning
confidence: 99%
“…Teriparatide has also been used with success in DMD, showing improvements in BMD and quality of life with few, if any, side effects (Catalano et al, 2016;Nasomyont et al, 2020). It is clear that routine imaging, particularly of the spine, clinical monitoring, consideration of skeletal delay, possible vitamin D supplementation and/or teriparatide treatment are needed when evaluating bone health and BMD Z-scores in patients with DMD (Ko et al, 2020).…”
Section: Neuromuscular Dystrophymentioning
confidence: 99%